Afrezza® Dosing Optimization Study

Clinical trial NCT04849845 · COMPLETED

Trial details

NCT number: NCT04849845
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2021-04-09
Primary completion: 2021-05-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.